Skip to content

True market access should involve coordinated approaches to patients and their healthcare providers

Steve Stefano and Dan Piggott co-author article for Pharmaceutical Commerce regarding specialty pharmaceuticals and their demand for integrated patient and prescriber approaches.

Although specialty medications reach smaller markets, their significantly higher pricing and quicker investment return from getting to market faster due to fewer clinical trial requirements, make them very attractive. Optimizing patient access to these new medicines is critical to success.

Once a life science company decides its specialty drug or biologic is ready to commercialize, the hard part – ensuring that the medicine actually reaches the intended patient population – begins. This journey from clinical trial to patient’s home is an arduous one; it requires careful planning with diligent execution to ensure integration of outreach efforts by market access, sales and nurse educator teams, as well as call centers and digital outreach to a multitude of touch points.

For the full article featured in Pharmaceutical Commerce, please click here: Pharmaceutical Commerce Business Strategies for BioPharma Success.